These putative positive correlations show that a high CDK1/PBK/CHEK1 expression promotes tumor growth, aggressiveness, and immune evasion through the increased recruitment of T Cells CD4+ Th2, MDSCs, and TAM-M2, all of which have pro-tumor effects. The gene discussed is CDK1; the disease is neoplasm.